GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 9 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $239,000 | -64.2% | 34,931 | -29.0% | 0.09% | -61.8% |
| Q3 2018 | $668,000 | +618.3% | 49,183 | +85.2% | 0.23% | +2812.5% |
| Q4 2016 | $93,000 | +43.1% | 26,556 | +80.6% | 0.01% | +33.3% |
| Q3 2016 | $65,000 | -19.8% | 14,707 | -19.0% | 0.01% | -45.5% |
| Q2 2016 | $81,000 | -5.8% | 18,148 | +4.6% | 0.01% | -8.3% |
| Q1 2016 | $86,000 | -33.3% | 17,348 | +2.4% | 0.01% | -25.0% |
| Q4 2015 | $129,000 | +10.3% | 16,948 | +7.3% | 0.02% | -11.1% |
| Q3 2015 | $117,000 | -19.3% | 15,788 | +9.5% | 0.02% | -25.0% |
| Q2 2015 | $145,000 | +11.5% | 14,416 | +4.3% | 0.02% | +41.2% |
| Q1 2015 | $130,000 | – | 13,816 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,832,484 | $13,469,000 | 1.47% |
| Knoll Capital Management, LLC | 206,099 | $1,515,000 | 1.24% |
| 683 Capital Management, LLC | 1,350,000 | $9,923,000 | 0.90% |
| Vivo Capital, LLC | 971,337 | $7,139,000 | 0.67% |
| P.A.W. CAPITAL CORP | 70,000 | $515,000 | 0.56% |
| Ibex Investors LLC | 807,400 | $5,934,000 | 0.48% |
| MEITAV INVESTMENT HOUSE LTD | 639,269 | $4,693,000 | 0.31% |
| Nantahala Capital Management | 879,200 | $6,559,000 | 0.20% |
| Rock Creek Group, LP | 57,201 | $420,000 | 0.19% |
| FIRST MIDWEST BANK TRUST DIVISION | 164,847 | $1,212,000 | 0.17% |